Literature DB >> 15926652

Perianal melanoma disguised as hemorrhoids: case report and discussion.

Vikisha T Fripp1, Jesus Esquivel, Carlos A Cerruto.   

Abstract

Perianal melanoma is a very rare disease that carries a grave prognosis. The difficulty in making the diagnosis and the rarity of the disease results in failure of recognition until the disease is widespread. Ultimately, the burden is on the physician to uncover this ominous cancer. Not doing so is one of the most significant correlates to poor outcome.

Entities:  

Mesh：

Year:  2005        PMID： 15926652      PMCID： PMC2569352     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  9 in total

1.  Anorectal melanoma--an incurable disease?

Authors:  C Thibault; P Sagar; S Nivatvongs; D M Ilstrup; B G Wolff
Journal:  Dis Colon Rectum       Date:  1997-06       Impact factor: 4.585

2.  Anal melanoma: an aggressive malignancy masquerading as hemorrhoids.

Authors:  M W Felz; G B Winburn; A M Kallab; J R Lee
Journal:  South Med J       Date:  2001-09       Impact factor: 0.954

3.  Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.

Authors:  R I Fisher; W D Terry; R J Hodes; S A Rosenberg; R Makuch; H G Gordon; S G Fisher
Journal:  Surg Clin North Am       Date:  1981-12       Impact factor: 2.741

4.  Changing epidemiology of anorectal melanoma.

Authors:  B Cagir; M H Whiteford; A Topham; J Rakinic; R D Fry
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

5.  Long-term survival after locally aggressive anorectal melanoma.

Authors:  B P Whooley; P Shaw; A B Astrow; I R Toth; M K Wallack
Journal:  Am Surg       Date:  1998-03       Impact factor: 0.688

Review 6.  Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center.

Authors:  M S Brady; J P Kavolius; S H Quan
Journal:  Dis Colon Rectum       Date:  1995-02       Impact factor: 4.585

7.  A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.

Authors:  U Veronesi; J Adamus; C Aubert; E Bajetta; G Beretta; G Bonadonna; R Bufalino; N Cascinelli; G Cocconi; J Durand; J De Marsillac; R L Ikonopisov; B Kiss; F Lejeune; R MacKie; G Madej; H Mulder; Z Mechl; G W Milton; A Morabito; H Peter; J Priario; E Paul; P Rumke; R Sertoli; R Tomin
Journal:  N Engl J Med       Date:  1982-10-07       Impact factor: 91.245

8.  Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases.

Authors:  P H Cooper; S E Mills; M S Allen
Journal:  Dis Colon Rectum       Date:  1982-10       Impact factor: 4.585

9.  DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040.

Authors:  G J Hill; S E Moss; F M Golomb; T B Grage; W S Fletcher; J P Minton; E T Krementz
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860
  9 in total
  3 in total

1.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

2.  Perianal melanoma with a BRAF gene mutation in a young Portuguese Roma native.

Authors:  Jennifer Tan
Journal:  BMJ Case Rep       Date:  2016-02-15

3.  Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.

Authors:  Conrado Martinez-Cadenas; Nuria Bosch; Lucas Peñas; Esther Flores-Couce; Enrique Ochoa; Javier Munárriz; Juan P Aracil; Marcos Tajahuerce; Ramón Royo; Rafael Lozoya; Enrique Boldó
Journal:  BMC Cancer       Date:  2011-08-09       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.